Brief: Cross Country Healthcare Q3 Adjusted EPS USD 0.39 Vs. IBES Estimate USD 0.41
01/11/2023 20:15
Nov 01 (Reuters) - Cross Country Healthcare Q3 adjusted EBITDA USD 27.248 million. * Q3 EPS USD 0.36 * Q3 gross margin 22% * Q3 net income USD 12.812 million * Q3 adjusted EBITDA margin 6.2% * Q3 revenue USD 442.291 million vs. IBES estimate USD 443.9 million
Recent news on Cross Country Healthcare
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Cross Country Healthcare Q1 revenue falls 18% but beats estimates
Brief: Cross Country Healthcare Q1 Adjusted EPS USD -0.03 Vs. IBES Estimate USD -0.04
Brief: Cross Country Healthcare To Be Acquired By Knox Lane In All-Cash Transaction Valued At $437 Million